Bright Minds Biosciences ... (DRUG)
35.16
-0.08 (-0.23%)
At close: Jan 15, 2025, 2:36 PM
Company Description
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases.
Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry.
The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin.
The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
Bright Minds Biosciences Inc.
| Country | CA |
| IPO Date | Mar 22, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | n/a |
| CEO | Ian McDonald |
Contact Details
Address: 1500 – 1055 West Georgia Street Vancouver, BC CA | |
| Website | https://brightmindsbio.com |
Stock Details
| Ticker Symbol | DRUG |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001827401 |
| CUSIP Number | 10919W108 |
| ISIN Number | CA10919W4056 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ian McDonald | Co-Founder, Chief Executive Officer, President & Director |
| Alex Vasilkevich | Chief Operating Officer & Vice President of Corporate Development |
| Ryan E. S. K. Cheung B.Com., CA, CPA | Chief Financial Officer |
| Dr. Emer Leahy M.B.A., Ph.D. | Consultant |
| Dr. Jan Torleif Pedersen M.Sc., Ph.D. | Chief Science Officer & Director |
| Dr. Mark A. Smith M.D., Ph.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 08, 2025 | 6-K | Filing |
| Dec 31, 2024 | 20-F | Filing |
| Nov 21, 2024 | 6-K | Filing |
| Nov 19, 2024 | D | Filing |
| Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 06, 2024 | 4 | Filing |
| Nov 06, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 05, 2024 | SC 13D/A | [Amend] Filing |
| Nov 05, 2024 | SC 13D/A | [Amend] Filing |
| Nov 05, 2024 | 6-K | Filing |